Western Australian Consolidated Regulations

POISONS REGULATIONS 1965 - REG 35A

35A .         Restrictions on retail sale of substances included in Schedule 3

        (1)         The retail sale of a substance included in Schedule 3 shall only be by way of direct, personal sale by a pharmaceutical chemist or graduate trainee in pharmacy under the personal supervision of a pharmaceutical chemist.

        (1a)         Before a substance included in Schedule 3 is delivered as part of a retail sale, the pharmaceutical chemist or graduate trainee shall take all reasonable steps to ensure that there is a therapeutic need for the substance.

        (1b)         A pharmaceutical chemist shall not store in any part of the retail area of premises any of the substances referred to in Appendix J.

        (1c)         A substance referred to in Appendix J shall only be sold or supplied by direct, personal sale by a pharmaceutical chemist or by a graduate trainee in pharmacy under the personal supervision of a pharmaceutical chemist and, in the case of pseudoephedrine, before it is delivered to the purchaser, the purchaser shall give photographic evidence of his or her identity to the pharmaceutical chemist or graduate trainee, unless the purchaser’s identity is known to the pharmaceutical chemist or graduate trainee.

        (2)         Before a substance referred to in Appendix J is delivered to a purchaser as part of a retail sale, the pharmaceutical chemist or graduate trainee making the sale shall —

            (a)         record in the prescription book referred to in regulation 36(3)(c) the following details —

                  (i)         the date of sale;

                  (ii)         the name and address of the purchaser;

                  (iii)         if the person for whom the substance is intended is not the purchaser, the name and address of that other person;

                  (iv)         the name and quantity of the substance supplied;

                and

            (b)         allocate to each sale a unique identification number or alpha-numerical code, and record that number or code in the register; and

            (c)         label the product containing the substance with —

                  (i)         the name and address of the pharmacy; and

                  (ii)         the number or code allocated under paragraph (b).

        (3)         The prescription book referred to in this regulation shall be available for inspection upon request by an authorised officer.

        (4)         The seller shall retain the records required to be made under this regulation for a period of at least 2 years.

        [Regulation 35A inserted in Gazette 28 Nov 1968 p. 3458; amended in Gazette 20 Sep 1985 p. 3743; 29 Aug 1990 p. 3028; 30 Nov 1990 p. 5908; 13 Dec 1991 p. 6190; 19 Mar 1996 p. 1221; 24 Jul 2007 p. 3664-5.]

[ 35AA.         Deleted in Gazette 11 Apr 1997 p. 1829.]